CF, Trauma, Blood Disorders Flashcards
6 adverse effects of surgical bleeding:
- Visual obstruction of the surgical field
- Reduction in core temp
- Thrombocytopenia
- Hypovolemic shock
- Need for blood transfusions
- Economic consequences
Normal physiologic coagulation process (4):
- Vascular constriction (limits flow of blood to the area)
- Platelet plug formation (adhesion, activation, aggregation)
- Fibrin formation (coagulation cascade: thrombin cleaves fibrinogen to fibrin)
- Fibrinolysis (clot dissolves to allow the normal BF after tissue repair)
What activates plasminogen to plasmin for fibrinolysis?
t-PA
- Provides global information on the dynamics of clot development, stabilization, and dissolution
- diagnosis of early trauma coagluopathies
Thromboelastography
What information does thromboelastography provide (4):
- Clotting time
- Max clot firmness
- Lysis index after 30 min
- Max lysis
What 4 diagnosis can thromboelastography provide (4):
- Hypercoagulability
- Hyperfibrinolysis
- Platelet dysfunction
- Hypocoagulability
3 mechanical methods to achieve surgical hemostasis:
- Direct pressure
- Fabric pad/gauze sponges/sponges
- Sutures/staples/ligating clips
3 thermal/energy-based methods to achieve surgical hemostasis:
- Electrosurgery
- Ultrasonic device
- Laser
2 chemical methods to achieve surgical hemostasis:
- Pharmacological agents
2. Topical hemostatic agents
4 indications for hemostatic agents:
- Cardiac surgery with cardiopulmonary bypass and other surgical procedures with significant blood loss
- Intraop significant blood loss
- Specific CF deficiencies, platelet dysfunction, or antithrombotics
- Refractory bleeding
2 antifibrinolytic agents
E-aminocaproic acid (EACA) Tranexamic acid (TXA)
Blocks the binding of plasminogen to fibrin and its activation to plasmin
Antifibrinolytic agents
2 uses for antifibrinolytic agents:
- Prophylactically to reduce surgical blood loss and transfusion
- Traumatic hemorrhage (TXA)
3 adverse effects of antifibrinolytic agents:
- Thromboembolic complications
- Hypotension (EACA)
- Seizures (TXA)
What is needed for patients with clinically important bleeding and low fibrinogen levels
Fibrinogen replacements
Prepared from plasma and contains fibrinogen, von willebrand factor, factor 8,13 and fibronectin
Cryoprecipitate
The need for cryoprecipitate?
Replacement of fibrinogen in hypofibrinogenemia
2 adverse effects of cryoprecipitate?
Infection and transfusion reactions
Difference between unactivated and activated prothrombin complex concentrate (PCC)?
Of 4 factors (2, 7, 9, 10), 7 is mostly active form
Activated does not contain heparin